UpdatesPress Release
JB Pharma's Q4 FY26 saw revenue at 904 Cr (-5% YoY) and net profit at 101 Cr (-30% YoY), impacted by post-acquisition integration.
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM · Filed with the exchange
FY26 revenue rose 6% to 4,148 Cr.
Management expects recovery from Q1, citing temporary impacts and improving margins from cost synergies.
No comments yet. Be the first.